Emission of Serie E Shares is intended to gain Money to finance the investment programme started In 2007 as well as for planned investment. The Company forecasts that gross receipts from emission of E Series Shares will be about 80 mln PLN, and the net income (after deducting the emission costs) will be about 78 mln PLN. The Company will cover the remaining amount of money indispensable to realize the planned actions and investments from its own money or loans and planned grants from European Union programmes (among others agreement signed in June 2007 with Polish Agency for Enterprise Development in programme 2.2.1. Sector Operating Programme Improvement of the Competitiveness of Enterprises, or other supportive sources available for companies (e.g. Minister of Science and Higher Education enterprise “Technological Initiative”) and also extinguishing the credit  of Technological Loan granted to Company.
The money gained by the Company will be spent from 2008 to 2009 to realize the aims.

Plans for spending money.
Expansion and development of offer which includes products made by the Company by taking over companies from medical branch – app. 40 mln PLN

Development of sales network in key markets – app. 10 mln PLN

Expansion of Company

    * Building new production hall with all facilities in the Company’s area in Zawiercie – app.  3,2 mln PLN
    * Building new headquarters for Group partnerships – app. 4,0 mln  PLN

Gaining the working capital – app. 10,8 mln PLN

TOTAL: 78,0 mln PLN

Expansion and development of Company’s offer by conducting research and development works on new devices for ophthalmologists and optometrists – approximately 10 mln PLN